About HONCH

Hubei Honch Pharmaceutical Co., Ltd., established in 2007, is located at Li Shizhen Pharmaeutical Industrial Park, Qichun County, Hubei Province, and covers an area of around 80000㎡. Honch is engaged in R&D and production of innovative anti-tumor, antibiotic, and high-end veterinary APIs. Honch was initially identified as a Hi-Tech enterprise in 2011 and has more than 20 domestic and foreign invention patents. Besides, Honch is a postgraduate workstation granted by the Hubei Provincial Department of Education and has won the Science & Technology Innovation Awards and Science & Technology Progress Awards of Hubei Province many times.

The characteristic of the pharmaceutical industry is “certify first, market later,"  while the standardization of quality systems is one of the core competitiveness of Honch. Honch has passed several on-site audits from NMPA China and US FDA; multiple products have obtained EU CEP certificates and have been registered in many countries, which indicate that Honch’s products can be sold in the global markets, including the European and US markets.

As a professional, specialized, innovative small-giant enterprise of national level, product processes focus on “Bio-fermentation + chemical synthesis” or “Plant extraction + chemical synthesis” API, and the products of Honch are the species of high barrier and high value in niche areas. Honch is the supplier for multiple originators; multiple products have a high market share in the world., among which Honch is the global exclusive API manufacturer of Ixabepilone.